7.79
price down icon0.26%   -0.02
after-market After Hours: 7.94 0.15 +1.93%
loading
Lifecore Biomedical Inc stock is traded at $7.79, with a volume of 133.30K. It is down -0.26% in the last 24 hours and down -5.23% over the past month. Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
See More
Previous Close:
$7.81
Open:
$7.86
24h Volume:
133.30K
Relative Volume:
0.76
Market Cap:
$291.86M
Revenue:
$128.45M
Net Income/Loss:
$6.54M
P/E Ratio:
155.80
EPS:
0.05
Net Cash Flow:
$-8.79M
1W Performance:
+2.10%
1M Performance:
-5.23%
6M Performance:
+14.06%
1Y Performance:
+2.77%
1-Day Range:
Value
$7.76
$7.93
1-Week Range:
Value
$7.34
$7.93
52-Week Range:
Value
$4.76
$8.85

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Name
Name
Lifecore Biomedical Inc
Name
Phone
(952) 368-4300
Name
Address
3515 LYMAN BOULEVARD, CHASKA
Name
Employee
406
Name
Twitter
Name
Next Earnings Date
2025-10-27
Name
Latest SEC Filings
Name
LFCR's Discussions on Twitter

Compare LFCR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
LFCR
Lifecore Biomedical Inc
7.79 292.61M 128.45M 6.54M -8.79M 0.05
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
118.66 51.85B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.33 45.46B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.52 42.70B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
29.79 34.62B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
493.99 21.03B 3.08B 1.24B 1.07B 25.61

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-04-25 Initiated KeyBanc Capital Markets Sector Weight
May-21-25 Initiated William Blair Outperform
Sep-05-24 Initiated Craig Hallum Buy
Aug-28-24 Downgrade Barrington Research Outperform → Mkt Perform
Mar-20-23 Downgrade Stephens Overweight → Equal-Weight

Lifecore Biomedical Inc Stock (LFCR) Latest News

pulisher
Dec 11, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Dec 11, 2025
pulisher
Dec 09, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Dec 09, 2025
pulisher
Dec 07, 2025

Is Lifecore Biomedical Inc a good long term investmentMarket Sentiment Report & High Yield Stock Picks - earlytimes.in

Dec 07, 2025
pulisher
Dec 07, 2025

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Dec 07, 2025
pulisher
Dec 07, 2025

Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights - The AI Journal

Dec 07, 2025
pulisher
Dec 05, 2025

Will Lifecore Biomedical Inc. (LDE) stock see insider accumulationWeekly Risk Report & Community Consensus Trade Signals - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Will Lifecore Biomedical Inc. (LDE) stock attract long term capital inflowsWall Street Watch & Accurate Entry/Exit Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

The Technical Signals Behind (LFCR) That Institutions Follow - news.stocktradersdaily.com

Dec 04, 2025
pulisher
Dec 03, 2025

Will Lifecore Biomedical Inc. (LDE) stock split increase liquidityMarket Risk Summary & Reliable Intraday Trade Alerts - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Will Lifecore Biomedical Inc. (LDE) stock benefit from sector leadership - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Will Lifecore Biomedical Inc. (LDE) stock keep raising dividendsBreakout Watch & Daily Stock Trend Watchlist - Newser

Dec 02, 2025
pulisher
Nov 30, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - ACCESS Newswire

Nov 30, 2025
pulisher
Nov 30, 2025

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirt - The National Law Review

Nov 30, 2025
pulisher
Nov 27, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Reach Out - ACCESS Newswire

Nov 27, 2025
pulisher
Nov 27, 2025

Can Lifecore Biomedical Inc. (LDE) stock deliver strong annual returnsJuly 2025 Analyst Calls & Technical Pattern Based Buy Signals - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 27, 2025

How sustainable is Lifecore Biomedical Inc. stock dividend payoutEarnings Growth Report & Technical Buy Zone Confirmations - moha.gov.vn

Nov 27, 2025
pulisher
Nov 25, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - ACCESS Newswire

Nov 25, 2025
pulisher
Nov 23, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect - ACCESS Newswire

Nov 23, 2025
pulisher
Nov 23, 2025

How Recent Developments Are Rewriting the Story for Lifecore Biomedical - Yahoo Finance

Nov 23, 2025
pulisher
Nov 22, 2025

Precision Trading with Lifecore Biomedical Inc. (LFCR) Risk Zones - news.stocktradersdaily.com

Nov 22, 2025
pulisher
Nov 21, 2025

Lifecore Biomedical (LFCR) Price Target Decreased by 12.50% to 8.92 - MSN

Nov 21, 2025
pulisher
Nov 20, 2025

How to interpret RSI for Lifecore Biomedical Inc. stockStop Loss & Fast Gaining Stock Strategy Reports - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Nov 20, 2025
pulisher
Nov 20, 2025

Lifecore Biomedical at Stephens Annual Investment Conference: Strategic Growth Path By Investing.com - Investing.com Canada

Nov 20, 2025
pulisher
Nov 20, 2025

Can Lifecore Biomedical Inc. stock surprise with earnings upsideQuarterly Performance Summary & AI Powered Buy and Sell Recommendations - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Lifecore Biomedical Inc. stock benefit from green energy trendsProfit Target & Daily Oversold Stock Bounce Ideas - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is Lifecore Biomedical Inc. stock ready for breakoutStop Loss & Short-Term High Return Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What candlestick patterns are forming on Lifecore Biomedical Inc.July 2025 Selloffs & Safe Entry Momentum Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Should I hold or sell Lifecore Biomedical Inc. stock in 2025July 2025 Recap & Capital Protection Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

How Lifecore Biomedical Inc. stock benefits from strong dollarMarket Rally & Expert-Curated Trade Recommendations - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Why pension funds invest in Lifecore Biomedical Inc. (LDE) stockBull Run & Technical Confirmation Trade Alerts - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire

Nov 18, 2025
pulisher
Nov 18, 2025

Lifecore Biomedical at Jefferies London: Strategic Growth Unveiled By Investing.com - Investing.com India

Nov 18, 2025

Lifecore Biomedical Inc Stock (LFCR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.21
price down icon 1.48%
$21.29
price up icon 0.09%
drug_manufacturers_specialty_generic RDY
$14.02
price down icon 0.50%
$11.65
price up icon 0.52%
$152.80
price down icon 1.26%
$493.99
price up icon 1.12%
Cap:     |  Volume (24h):